Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study | Zendy

Helen Kovari | Zendy; Caroline Sabin | Zendy; Bruno Ledergerber | Zendy; Lene Ryom | Zendy; Signe Westring Worm | Zendy; Colette Smith | Zendy; Andrew Phillips | Zendy; Peter Reiss | Zendy; Éric Fontas | Zendy; Kathy Petoumenos | Zendy; Stéphane De Wit | Zendy; Philippe Morlat | Zendy; Jens Lundgren | Zendy; Rainer Weber | Zendy

Open Access

Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study

Author(s) -

Helen Kovari,

Caroline Sabin,

Bruno Ledergerber,

Lene Ryom,

Signe Westring Worm,

Colette Smith,

Andrew Phillips,

Peter Reiss,

Éric Fontas,

Kathy Petoumenos,

Stéphane De Wit,

Philippe Morlat,

Jens Lundgren,

Rainer Weber

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis919

Subject(s) - medicine , coinfection , hepatitis c , hepatitis c virus , hepatitis b , adverse effect , mortality rate , hepatitis b virus , incidence (geometry) , immunology , virology , human immunodeficiency virus (hiv) , virus , physics , optics

Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research